Sirio Pharma Co., Ltd’s acquisition of Ayanda GmbH & Co. KG


DLA Piper has advised Sirio Pharma Co., Ltd, one of China’s largest healthcare product manufacturers, on the acquisition of Ayanda GmbH & Co. KG, a vitamin and supplement manufacturer, from its holding company Ayanda AS for an undisclosed sum.

This was the first investment for Sirio in Europe.

Sirio Pharma Co., Ltd. is a global integrated contract manufacturer for dietary supplements, drugs and cosmetics, providing a wide range of products with different forms. The company’s head office is in Shantou, China. It has two factories, exports to over 50 countries and employs a total of 1,200 employees.

Privately held company Ayanda, founded in 1992, is a worldwide vitamin and supplement manufacturer providing private label products for the nutraceutical and dietary supplement industry. It is based in Germany.

The international DLA Piper deal team was led by partners Dr Nils Krause (Picture) (Corporate, Hamburg) and Sheng Wu (Corporate, Hong Kong) and consisted of Dr Jan-Philipp Meier (Corporate, Hamburg) partners Dr Burkhard Fuehrmeyer (IPT), Dr Michael Holzhaeuser (Antitrust) and Dr Konrad Rohde (Tax, all Frankfurt), counsels Gabriele Engels (IPT), Dr Thilo Streit (Litigation & Regulatory, both Cologne), Dr Annemarie Bloß (Hamburg), Dr Fabian Klein (Frankfurt, both IPT) and Dr Christoph Imschweiler (Tax, Munich), senior associates Dr Danguole Hackel (Corporate, Hamburg), Niklas Mangels (Corporate, Frankfurt), Dr Bahne Sievers (IPT), Dr Henriette Norda (Employment, both Hamburg) and Semin O (Antitrust, Frankfurt) and as associates Ronja Hecker (Corporate, Hamburg), Dr Heiner Feldhaus (Real Estate), Spela Kastelec (Litigation & Regulatory, both Cologne) and Dr Christina Heinz (Employment, Hamburg) as well as transaction lawyer Hui Hao (Corporate, Hamburg).

Involved fees earner: Nils Krause – DLA Piper; Sheng Wu – DLA Piper; Jan-Philipp Meier – DLA Piper; Danguole Hackel – DLA Piper; Niklas Mangels – DLA Piper; Ronja Hecker – DLA Piper; Hui Hao – DLA Piper; Marvin Qin – DLA Piper; Jonathan Wong – DLA Piper; Jeffrey Yu – DLA Piper; Yuxiang Zhang – DLA Piper; Burkhard Fuehrmeyer – DLA Piper; Gabriele Engels – DLA Piper; Annemarie Bloss – DLA Piper; Fabian Klein – DLA Piper; Bahne Sievers – DLA Piper; Michael Holzhaeuser – DLA Piper; Semin O – DLA Piper; Konrad Rohde – DLA Piper; Christoph Imschweiler – DLA Piper; Henriette Norda – DLA Piper; Christina Heinz – DLA Piper; Heiner Feldhaus – DLA Piper; Thilo Streit – DLA Piper; Spela Kastelec – DLA Piper;

Law Firms: DLA Piper;

Clients: Sirio Pharma Co., Ltd;